Published in Arthritis Res Ther on April 28, 2006
Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy. Arthritis Care Res (Hoboken) (2012) 2.72
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther (2008) 2.15
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis (2011) 2.01
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis (2007) 1.46
A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis. Rheumatol Int (2011) 1.45
Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis (2009) 1.27
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol (2013) 1.20
Rheumatoid arthritis and cardiovascular disease. Am Heart J (2013) 1.14
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther (2008) 1.12
Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2008) 1.11
Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2009) 1.10
Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag (2007) 1.08
Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol (2015) 1.02
Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2010) 0.91
The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J Lipid Res (2008) 0.90
Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study. Arthritis Res Ther (2008) 0.90
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Ther Adv Musculoskelet Dis (2013) 0.89
High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study. Arthritis Res Ther (2012) 0.88
Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients. Rheumatol Int (2013) 0.88
Rheumatoid arthritis and cardiovascular disease: an update on treatment issues. Curr Opin Rheumatol (2013) 0.87
Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis. Arthritis Res Ther (2015) 0.85
Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass--a cross sectional study. BMC Musculoskelet Disord (2011) 0.85
Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study. J Rheumatol (2013) 0.84
Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2. Arthritis Res Ther (2007) 0.83
Metabolic syndrome in rheumatoid arthritis. Maedica (Buchar) (2012) 0.82
Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics. Eur J Endocrinol (2012) 0.81
Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients. Rheumatol Int (2014) 0.80
Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis. PLoS One (2016) 0.80
Risk factors for coronary heart disease in connective tissue diseases. Ther Adv Musculoskelet Dis (2010) 0.79
Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis. PLoS One (2016) 0.79
Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study. Arthritis Care Res (Hoboken) (2013) 0.79
Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors. Arch Drug Inf (2008) 0.78
Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella. J Lipid Res (2009) 0.78
Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study. Nutr Res Pract (2015) 0.77
The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis. Rheumatol Int (2010) 0.77
Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis. Clin Rheumatol (2015) 0.77
IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis. Sci Rep (2017) 0.75
Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity. Saudi Med J (2015) 0.75
Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis. J Korean Med Sci (2015) 0.75
Serum Lipid Alterations in Early Rheumatoid Arthritis Patients on Disease Modifying Anti Rheumatoid Therapy. Indian J Clin Biochem (2016) 0.75
Serum lipid changes and insulin resistance in familial Mediterranean fever. Eur J Rheumatol (2014) 0.75
Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate? Iran J Pharm Res (2016) 0.75
Cardiovascular comorbidities of rheumatoid arthritis in Taiwanese adults: A retrospective single-center study. Ci Ji Yi Xue Za Zhi (2017) 0.75
[Therapy of dyslipidemia in rheumatic diseases]. Z Rheumatol (2010) 0.75
Disease activity, obesity, functional disability, and depression in patients with rheumatoid arthritis : Impact on lipid status, glycoregulation, and risk for coronary heart disease. Z Rheumatol (2016) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum (2001) 5.87
Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med (2001) 4.15
Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol (1997) 3.65
Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum (2003) 3.35
Plasma cholesteryl ester transfer protein. J Lipid Res (1993) 3.18
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA (1988) 2.89
Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum (2002) 2.62
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol (1999) 2.58
Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum (1986) 2.55
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J (1986) 2.55
All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol (2003) 2.52
Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum (2000) 2.29
Bone destruction in arthritis. Ann Rheum Dis (2002) 2.15
Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med (2002) 2.13
Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) (1985) 2.10
Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol (2000) 2.10
Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum (2001) 2.08
Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol (1999) 1.93
A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation (1999) 1.93
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.91
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87
Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum (1992) 1.51
Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study. J Rheumatol (2002) 1.50
Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum (1992) 1.46
Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun (2002) 1.40
Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol (2002) 1.37
Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol (2001) 1.35
Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum (1992) 1.31
Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. Atheroscler Suppl (2002) 1.21
Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.20
Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Circulation (2001) 1.11
Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med (1987) 1.07
Dyslipidemia and rheumatoid arthritis. Ann Rheum Dis (1997) 1.06
Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol (2002) 1.06
Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J Lipid Res (2002) 1.00
Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases. J Rheumatol (1991) 0.97
Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis. Br J Rheumatol (1985) 0.93
The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia. Atherosclerosis (2004) 0.91
Rheumatoid arthritis and cardiovascular disease may share similar risk factors. Rheumatology (Oxford) (2001) 0.88
Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians. Circulation (2005) 0.84
Survival in rheumatoid arthritis. Arthritis Rheum (1987) 0.83
Methotrexate treatment and mortality in rheumatoid arthritis. Lancet (2002) 0.79
[Plasma levels of apolipoprotein and HDL-cholesterol in patients with rheumatoid arthritis]. Boll Soc Ital Biol Sper (1984) 0.78
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum (2006) 2.90
Epidemiology of adult rheumatoid arthritis. Autoimmun Rev (2005) 2.62
Fertility in male patients with seronegative spondyloarthropathies treated with infliximab. Joint Bone Spine (2012) 2.01
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes. Circulation (2004) 1.91
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum (2008) 1.76
Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum (2008) 1.51
Ear involvement in systemic lupus erythematosus patients: a comparative study. J Laryngol Otol (2002) 1.51
Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study. J Rheumatol (2002) 1.50
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler Thromb Vasc Biol (2007) 1.42
Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. Thyroid (2003) 1.40
Secondary sex ratio in Greece: evidence of an influence by father's occupational exposure. Hum Reprod (2007) 1.40
Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma. Clin Chem (2005) 1.40
The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia. Curr Med Res Opin (2011) 1.39
α-Defensins and hsCRP levels in inflammatory response of standard and laparoendoscopic single-site cholecystectomy. Surg Endosc (2011) 1.38
The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Biochim Biophys Acta (2009) 1.26
Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol (2008) 1.16
A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine (2010) 1.15
LDL cholesterol estimation in patients with the metabolic syndrome. Lipids Health Dis (2006) 1.12
Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmun Rev (2013) 1.09
Infliximab therapy in established rheumatoid arthritis: an observational study. Am J Med (2005) 1.09
Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol (2006) 1.08
Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. J Immunol (2010) 1.06
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2. Arterioscler Thromb Vasc Biol (2007) 1.05
Primary Sjögren syndrome in the paediatric age: a multicentre survey. Eur J Pediatr (2003) 1.04
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria. Metabolism (2006) 1.02
Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001. J Rheumatol (2003) 1.01
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opin Biol Ther (2007) 1.01
Clinical pharmacology of celecoxib, a COX-2 selective inhibitor. Expert Opin Pharmacother (2007) 1.01
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr Vasc Pharmacol (2011) 1.00
Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J Lipid Res (2002) 1.00
Global vasomotor dysfunction and accelerated vascular aging in beta-thalassemia major. Atherosclerosis (2007) 1.00
Oxidative stress markers in laparoscopic versus open colectomy for cancer: a double-blind randomized study. Surg Endosc (2013) 1.00
Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther (2014) 0.98
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia. Curr Med Res Opin (2007) 0.96
The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer. Anticancer Res (2003) 0.96
Early rheumatoid arthritis patients: relationship of age. Rheumatol Int (2002) 0.95
The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis. Clin Rheumatol (2013) 0.94
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles. Lipids (2007) 0.94
Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patients. Clin Biochem (2004) 0.94
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB. Arterioscler Thromb Vasc Biol (2002) 0.93
Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia. Angiology (2005) 0.93
Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum (2005) 0.93
Low back pain in a representative sample of Greek population: analysis according to personal and socioeconomic characteristics. Spine (Phila Pa 1976) (2004) 0.93
Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol (2013) 0.93
Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review. Expert Rev Pharmacoecon Outcomes Res (2014) 0.93
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia. Clin Ther (2007) 0.92
Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum (2008) 0.92
High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuria. J Lipid Res (2006) 0.91
Does psychological distress vary between younger and older adults in health and disease? J Psychosom Res (2011) 0.91
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids (2006) 0.91
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr Vasc Pharmacol (2011) 0.90
Effects of nutritional intervention on body weight and body composition of obese psychiatric patients taking olanzapine. Nutrition (2009) 0.90
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes. Biochem Res Int (2011) 0.90
Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int (2014) 0.89
Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study. J Rheumatol (2009) 0.89
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer (2004) 0.89
Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of Mediterranean European populations. Semin Arthritis Rheum (2002) 0.89
Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J Rheumatol (2003) 0.89
Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res (2007) 0.89
Diagnostic accuracy, internal consistency, and convergent validity of the Greek version of the patient health questionnaire 9 in diagnosing depression in rheumatologic disorders. Arthritis Care Res (Hoboken) (2011) 0.89
Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3). Eur J Biochem (2003) 0.88
miRNAs and related polymorphisms in rheumatoid arthritis susceptibility. Autoimmun Rev (2011) 0.88
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia. Expert Opin Pharmacother (2011) 0.88
Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study. J Cardiovasc Pharmacol Ther (2012) 0.88
Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study. Atherosclerosis (2008) 0.88
Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res (Hoboken) (2012) 0.87
Adult-onset Still's disease: clinical, serological and therapeutic considerations. Clin Exp Rheumatol (2012) 0.87
Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study. J Cardiovasc Pharmacol Ther (2006) 0.87
Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins. J Lipid Res (2003) 0.87
Isolated intraparotid Kaposi sarcoma in human immunodeficiency virus type 1 infection. Mayo Clin Proc (2003) 0.87
Periocular xanthogranuloma: A forgotten entity? Clin Ophthalmol (2010) 0.87
The usefulness of magnetic resonance imaging of the hand and wrist in very early rheumatoid arthritis. Arthritis Res Ther (2011) 0.86
The impact of psychological functioning upon systemic sclerosis patients' quality of life. Semin Arthritis Rheum (2007) 0.86
Transcription regulatory polymorphism -43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy. Rheumatol Int (2007) 0.86
Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome. Prostaglandins Leukot Essent Fatty Acids (2005) 0.86
Visceral leishmaniasis resembling systemic lupus erythematosus. Clin Rheumatol (2003) 0.85
Genetics in rheumatoid arthritis beyond HLA genes: what meta-analyses have shown? Semin Arthritis Rheum (2013) 0.85
Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles. Arterioscler Thromb Vasc Biol (2006) 0.85
Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis. Autoimmun Rev (2010) 0.84
Premature atherosclerosis in non-transfusion-dependent β-thalassemia intermedia. Cardiology (2011) 0.84
No effect of CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemia. Drug Metabol Personal Ther (2015) 0.84
Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders. Qual Life Res (2009) 0.84
Adalimumab in the treatment of rheumatoid arthritis. Expert Opin Biol Ther (2012) 0.84
Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets. Platelets (2012) 0.83
Radiological cervical spine involvement in patients with rheumatoid arthritis: a cross sectional study. J Rheumatol (2005) 0.83
Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2. Arthritis Res Ther (2007) 0.83